TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer

TP53 overexpression is indicative of somatic TP53 mutations and associates with aggressive tumors and poor prognosis in breast cancer. We utilized a two-stage SNP association study to detect variants associated with breast cancer survival in a TP53-dependent manner. Initially, a genome-wide study (n...

Descripción completa

Detalles Bibliográficos
Autores principales: Fagerholm, Rainer, Khan, Sofia, Schmidt, Marjanka K., GarcClosas, Montserrat, Heikkilä, Päivi, Saarela, Jani, Beesley, Jonathan, Jamshidi, Maral, Aittomäki, Kristiina, Liu, Jianjun, Raza Ali, H., Andrulis, Irene L., Beckmann, Matthias W., Behrens, Sabine, Blows, Fiona M., Brenner, Hermann, Chang-Claude, Jenny, Couch, Fergus J., Czene, Kamila, Fasching, Peter A., Figueroa, Jonine, Floris, Giuseppe, Glendon, Gord, Guo, Qi, Hall, Per, Hallberg, Emily, Hamann, Ute, Holleczek, Bernd, Hooning, Maartje J., Hopper, John L., Jager, Agnes, Kabisch, Maria, Investigators, kConFab/AOCS, Keeman, Renske, Kosma, Veli-Matti, Lambrechts, Diether, Lindblom, Annika, Mannermaa, Arto, Margolin, Sara, Provenzano, Elena, Shah, Mitul, Southey, Melissa C., Dennis, Joe, Lush, Michael, Michailidou, Kyriaki, Wang, Qin, Bolla, Manjeet K., Dunning, Alison M., Easton, Douglas F., Pharoah, Paul D.P ., Chenevix-Trench, Georgia, Blomqvist, Carl, Nevanlinna, Heli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392336/
https://www.ncbi.nlm.nih.gov/pubmed/28179588
http://dx.doi.org/10.18632/oncotarget.15110

Ejemplares similares

Ejemplares similares